The diagnostic utility of TP53 and CDKN2A to distinguish ovarian high-grade serous carcinoma from low-grade serous ovarian tumors
Published 2013 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
The diagnostic utility of TP53 and CDKN2A to distinguish ovarian high-grade serous carcinoma from low-grade serous ovarian tumors
Authors
Keywords
-
Journal
MODERN PATHOLOGY
Volume 26, Issue 9, Pages 1255-1263
Publisher
Springer Nature
Online
2013-04-05
DOI
10.1038/modpathol.2013.55
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- MEK1/2 Inhibition Elicits Regression of Autochthonous Lung Tumors Induced by KRASG12D or BRAFV600E
- (2012) C. L. Trejo et al. CANCER RESEARCH
- Hormonal therapy for recurrent low-grade serous carcinoma of the ovary or peritoneum
- (2012) David M. Gershenson et al. GYNECOLOGIC ONCOLOGY
- Ovarian low-grade serous carcinoma: A comprehensive update
- (2012) Ivan Diaz-Padilla et al. GYNECOLOGIC ONCOLOGY
- Architectural Patterns of Ovarian/Pelvic High-grade Serous Carcinoma
- (2012) Amy B. Bromley et al. INTERNATIONAL JOURNAL OF GYNECOLOGICAL PATHOLOGY
- Unresponsiveness of colon cancer to BRAF(V600E) inhibition through feedback activation of EGFR
- (2012) Anirudh Prahallad et al. NATURE
- Immunohistochemical testing of BRAF V600E status in 1,120 tumor tissue samples of patients with brain metastases
- (2011) David Capper et al. ACTA NEUROPATHOLOGICA
- Which is the better surgical strategy for newly diagnosed epithelial ovarian cancer
- (2011) Paul J. Hoskins CURRENT OPINION IN ONCOLOGY
- Low-grade serous primary peritoneal carcinoma
- (2011) Kathleen M. Schmeler et al. GYNECOLOGIC ONCOLOGY
- Patterns of p53 immunoreactivity in endometrial carcinomas: ‘all or nothing’ staining is of importance
- (2011) W Glenn McCluggage et al. HISTOPATHOLOGY
- Biomarker Expression in Pelvic High-grade Serous Carcinoma
- (2011) Martin Köbel et al. INTERNATIONAL JOURNAL OF GYNECOLOGICAL PATHOLOGY
- Low-grade serous carcinomas of the ovary contain very few point mutations
- (2011) Siân Jones et al. JOURNAL OF PATHOLOGY
- Immunohistochemical staining patterns of p53 can serve as a surrogate marker for TP53 mutations in ovarian carcinoma: an immunohistochemical and nucleotide sequencing analysis
- (2011) Anna Yemelyanova et al. MODERN PATHOLOGY
- Integrated genomic analyses of ovarian carcinoma
- (2011) D. Bell et al. NATURE
- Improved Survival with Vemurafenib in Melanoma with BRAF V600E Mutation
- (2011) Paul B. Chapman et al. NEW ENGLAND JOURNAL OF MEDICINE
- BRAF Mutation Is Rare in Advanced-Stage Low-Grade Ovarian Serous Carcinomas
- (2010) Kwong-Kwok Wong et al. AMERICAN JOURNAL OF PATHOLOGY
- Diagnosis of Ovarian Carcinoma Cell Type is Highly Reproducible
- (2010) Martin Köbel et al. AMERICAN JOURNAL OF SURGICAL PATHOLOGY
- Diagnosis of epithelial ovarian carcinoma prior to neoadjuvant chemotherapy
- (2010) O.C. Freedman et al. GYNECOLOGIC ONCOLOGY
- Differences in Tumor Type in Low-stage Versus High-stage Ovarian Carcinomas
- (2010) Martin Köbel et al. INTERNATIONAL JOURNAL OF GYNECOLOGICAL PATHOLOGY
- Loss of p16INK4A Expression in Low-grade Ovarian Serous Carcinomas
- (2010) Peter W. Schlosshauer et al. INTERNATIONAL JOURNAL OF GYNECOLOGICAL PATHOLOGY
- Driver mutations in TP53 are ubiquitous in high grade serous carcinoma of the ovary
- (2010) Ahmed Ashour Ahmed et al. JOURNAL OF PATHOLOGY
- The biological and clinical value of p53 expression in pelvic high-grade serous carcinomas
- (2010) Martin Köbel et al. JOURNAL OF PATHOLOGY
- Calculator for ovarian carcinoma subtype prediction
- (2010) Steve E Kalloger et al. MODERN PATHOLOGY
- Neoadjuvant Chemotherapy or Primary Surgery in Stage IIIC or IV Ovarian Cancer
- (2010) Ignace Vergote et al. NEW ENGLAND JOURNAL OF MEDICINE
- Ovarian Low-grade and High-grade Serous Carcinoma
- (2009) Russell Vang et al. ADVANCES IN ANATOMIC PATHOLOGY
- Recurrent low-grade serous ovarian carcinoma is relatively chemoresistant
- (2009) David M. Gershenson et al. GYNECOLOGIC ONCOLOGY
- Critical molecular abnormalities in high-grade serous carcinoma of the ovary
- (2008) Martin Köbel et al. EXPERT REVIEWS IN MOLECULAR MEDICINE
- Neoadjuvant chemotherapy for low-grade serous carcinoma of the ovary or peritoneum
- (2008) Kathleen M. Schmeler et al. GYNECOLOGIC ONCOLOGY
- Low-grade serous ovarian cancer: a unique disease
- (2008) Kathleen M. Schmeler et al. Current Oncology Reports
- Ovarian Carcinoma Subtypes Are Different Diseases: Implications for Biomarker Studies
- (2008) Martin Köbel et al. PLOS MEDICINE
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now